Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $612000.0.

  • Exagen's Depreciation & Amortization (CF) rose 4502.37% to $612000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 644.27%. This contributed to the annual value of $1.7 million for FY2024, which is 2047.97% down from last year.
  • As of Q3 2025, Exagen's Depreciation & Amortization (CF) stood at $612000.0, which was up 4502.37% from $466000.0 recorded in Q2 2025.
  • In the past 5 years, Exagen's Depreciation & Amortization (CF) registered a high of $612000.0 during Q3 2025, and its lowest value of $187000.0 during Q1 2021.
  • Over the past 5 years, Exagen's median Depreciation & Amortization (CF) value was $440000.0 (recorded in 2022), while the average stood at $416578.9.
  • Per our database at Business Quant, Exagen's Depreciation & Amortization (CF) surged by 9540.64% in 2023 and then crashed by 3024.79% in 2024.
  • Quarter analysis of 5 years shows Exagen's Depreciation & Amortization (CF) stood at $292000.0 in 2021, then skyrocketed by 78.08% to $520000.0 in 2022, then dropped by 2.5% to $507000.0 in 2023, then dropped by 18.15% to $415000.0 in 2024, then surged by 47.47% to $612000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $612000.0 in Q3 2025, compared to $466000.0 in Q2 2025 and $440000.0 in Q1 2025.